We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$32.2B
AUM Growth
+$1.15B
Cap. Flow
+$886M
Cap. Flow %
2.75%
Top 10 Hldgs %
14.34%
Holding
3,060
New
26
Increased
2,468
Reduced
355
Closed
63

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$23.3M
2
XOM icon
ExxonMobil
XOM
+$22.8M
3
AAPL icon
Apple
AAPL
+$21.5M
4
WFC icon
Wells Fargo
WFC
+$19.8M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 14.4%
2 Financials 14.39%
3 Healthcare 13.67%
4 Industrials 10.84%
5 Consumer Discretionary 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLGT icon
2926
Radiant Logistics
RLGT
$392M
$77K ﹤0.01%
21,431
+180
+0.8% +$595
NVTR
2927
DELISTED
Nuvectra Corporation Common Stock
NVTR
$77K ﹤0.01%
+14,177
New +$76.3K
NWG icon
2928
NatWest
NWG
$76.5B
$74K ﹤0.01%
+10,698
New +$81.1K
HLTH
2929
DELISTED
Nobilis Health Corp.
HLTH
$74K ﹤0.01%
23,862
BTU
2930
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
$74K ﹤0.01%
31,823
+2,460
+8% +$9.14K
CDMO
2931
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$73K ﹤0.01%
24,663
+2,233
+10% +$12K
MT icon
2932
ArcelorMittal
MT
$56.8B
$72K ﹤0.01%
5,273
-20
-0.4% -$193
RYZ
2933
Ryerson Holding Corp
RYZ
$1.43B
$72K ﹤0.01%
12,925
+1,390
+12% +$5.42K
ASMB icon
2934
Assembly Biosciences
ASMB
$526M
$71K ﹤0.01%
1,184
+7
+0.6% +$468
VSTM icon
2935
Verastem
VSTM
$516M
$71K ﹤0.01%
3,769
+338
+10% +$5.43K
CCXI
2936
DELISTED
ChemoCentryx, Inc.
CCXI
$71K ﹤0.01%
28,635
NWBO
2937
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$69K ﹤0.01%
47,196
+200
+0.4% +$395
VCYT icon
2938
Veracyte
VCYT
$3.71B
$68K ﹤0.01%
12,553
VALE.P
2939
DELISTED
Vale S A
VALE.P
$68K ﹤0.01%
21,890
HNRG icon
2940
Hallador Energy
HNRG
$696M
$67K ﹤0.01%
14,633
+1,125
+8% +$5.42K
IMN
2941
DELISTED
Imation
IMN
$67K ﹤0.01%
43,438
+3,380
+8% +$3.68K
GOGL
2942
DELISTED
Golden Ocean Group
GOGL
$66K ﹤0.01%
18,895
+1,865
+11% +$6.38K
INSG icon
2943
Inseego
INSG
$121M
$65K ﹤0.01%
3,673
AREX
2944
DELISTED
Approach Resources Inc.
AREX
$65K ﹤0.01%
56,261
+5,125
+10% +$5.83K
OREX
2945
DELISTED
Orexigen Therapeutics, Inc.
OREX
$65K ﹤0.01%
11,544
+178
+2% +$2.31K
ELDN icon
2946
Eledon Pharmaceuticals
ELDN
$266M
$64K ﹤0.01%
70
+3
+4% +$2.94K
REXX
2947
DELISTED
Rex Energy Corporation
REXX
$63K ﹤0.01%
8,216
+678
+9% +$6.01K
UEC icon
2948
Uranium Energy
UEC
$5.31B
$62K ﹤0.01%
82,658
ENPH icon
2949
Enphase Energy
ENPH
$5.15B
$61K ﹤0.01%
26,361
VSLR
2950
DELISTED
VIVINT SOLAR, INC.
VSLR
$59K ﹤0.01%
22,215
+1,095
+5% +$7.05K

Similar funds

RhumbLine Advisers's Q1 2016 Portfolio in Review

As of Q1 2016, RhumbLine Advisers held 3,060 positions worth $32.2B, up 3.7% from $31.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2016: portfolio turnover was 2.9%. RhumbLine Advisers opened 26 new positions and exited 63, leaving the 3,060-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2016 buy was Willis Towers Watson: 89,353 shares worth $10.6M.
  • RhumbLine Advisers added most to Broadcom in Q1 2016, an estimated $23.3M increase.
  • RhumbLine Advisers's biggest Q1 2016 reduction was Chubb, cutting an estimated $13.7M.
  • RhumbLine Advisers fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $43M.
  • RhumbLine Advisers's ten largest holdings make up 14% of its $32.2B portfolio in Q1 2016.
  • RhumbLine Advisers opened 26 new positions and closed 63 in Q1 2016.
  • RhumbLine Advisers's portfolio value rose 3.7% quarter-over-quarter to $32.2B.

Based on RhumbLine Advisers's 13F filing for Q1 2016, filed 2 May 2016.